Valor202020212022202320242025TTMGastos comerciales, generales y administrativos2.47 B2.87 B3.89 B3.95 B2.97 B2.89 B2.92 BInvestigación y desarrollo521 M534 M605 M667 M590 M518 M517 MBeneficio operativo1.62 B1.71 B-1.94 B390 M14 M-308 M-300 MTotal de ingresos no operativos-272 M-45 M-56 M-30 M101 M81 M14 MGastos por intereses, netos de intereses capitalizados153 M206 M415 M512 M408 M290 M—Ingresos no operativos, una vez deducidos los gastos por intereses-235 M-210 M-456 M-491 M-345 M-250 M-95 MIngresos/gastos extraordinarios-190 M-41 M-15 M-51 M38 M41 M32 MBeneficio antes de impuestos1.29 B1.48 B-2.35 B-103 M-289 M-505 M-508 MParticipación en los beneficios———————Impuestos182 M182 M68 M-34 M37 M395 M473 MParticipación minoritaria8 M11 M12 M7 M11 M00Otros ingresos/gastos después de impuestos-86 M-92 M12 M-77 M-41 M-30 M-37 MBeneficio neto antes de actividades interrumpidas1.1 B1.28 B-2.43 B-76 M-337 M-900 M-981 MOperaciones suspendidas0——2.73 B-312 M-57 M-117 MBeneficio neto1.1 B1.28 B-2.43 B2.66 B-649 M-957 M-1.1 BAjuste por dilución———————Dividendos de las acciones preferentes———————Beneficio neto diluido atribuible a los accionistas1.1 B1.28 B-2.43 B2.66 B-649 M-957 M-1.1 BBeneficio básico por acción2.172.56-4.835.25-1.27-1.87-2.15Beneficio por acción diluido2.132.53-4.835.25-1.27-1.87-2.15Número medio de acciones ordinarias509 M502 M504 M506 M510 M513 M—Acciones diluidas517 M508 M504 M506 M510 M513 M—EBITDA1.67 B1.82 B-1.94 B-231 M-239 M-1 B-1.16 BEBIT488 M551 M-4.27 B-2.35 B-1.22 B-1.98 B-2.13 BCosto de los ingresos7.09 B7.68 B9.72 B9.84 B6.65 B7.87 B7.91 BOtros costes de producción———14 M9 M——Amortización y depreciación (flujo de caja)823 M890 M1.4 B1.26 B997 M981 M971 M
Baxter International Inc. Common Stock
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois.
The company primarily focuses on products to treat chronic and acute medical conditions. The company had 2023 global net sales of $14.8 billion, across three business: "Medical Product and Therapies", "Healthcare Systems and Technologies" and Pharmaceuticals.
Baxter's Medical Product and Therapies business comprise two divisions: the first named "Advanced Surgery" that produce technologies to enhance surgeons' technique, increase efficiencies and improve outcomes. The second named "Infusion Therapies and Technologies" produces intravenous products and other products used in the delivery of fluids and drugs to patients.
Baxter's Healthcare System and Technologies business has four divisions "Front Line Care", "Digital Platform and Innovations", "Care and Connectivity Solutions" and "Global Services".
Baxter's Pharmaceuticals business produce inhalational anaesthetics and other differentiated hospital pharmaceuticals in areas of pain, critical care, anti-infection and oncology.